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Objective: This study aimed to measure the outcomes that patients consider clinically 
  meaningful across four treatment domains – (1) pain, (2) fatigue, (3) emotional distress, and (4) 
level of interference – and determine if patients met their own success criteria. Additionally, the 
role of expectations in treatment outcome was examined. This study also aimed to determine 
how change in levels of pain, fatigue, disability, and level of interference varied according to 
the type of treatment delivered to participants.
Patients: Forty-seven chronic low back pain patients were recruited from university-affiliated 
pain clinics.
Design: The study design was longitudinal, consisting of two randomly assigned treatment 
conditions. The first treatment condition used opioid medication only and the second used both 
opioid medication and brief cognitive behavioral therapy. Pre- and post-treatment assessments 
were conducted, which occurred approximately 3 months after the initiation of treatment.
Outcome measures: A patient-centered outcomes questionnaire was completed by partici-
pants at both pre- and post-treatment assessment.
Results: Results suggest that patients did not meet their own success criteria in treatment across 
any of the four domains. There was a significant main effect of time for level of pain indicating 
that both treatment groups had a decrease in their level of pain at post-treatment, F(1, 45) = 11.98, 
P , 0.001. There was a significant main effect of time for level of interference domain indicat-
ing that both groups experienced a reduction in the level of pain-related interference with daily 
activities, F(1, 45) = 5.46, P , 0.05. There were no significant effects of time for emotional 
distress or fatigue or any significant group by time interactions. Contrary to our hypothesis, no 
significant correlations were found between pretreatment expectations and usual level ratings 
at post-treatment across the four domains.
Conclusion: Patients sought larger reductions in pain, fatigue, level of distress, and level of 
interference than they attained at post-treatment. Enhancing opioid treatment with brief cogni-
tive behavioral therapy did not yield additional improvements for the four domains assessed in 
patients with chronic low back pain.
Keywords: patient centered, chronic pain, expectations, treatment outcome, cognitive behav-
ioral therapy
Introduction
The National Center for Health Statistics reported that one in four adult Americans 
stated that they experienced a period of pain lasting more than 24 hours within the 
previous month; one in ten people reported the pain being present for a minimum 
duration of 1 year.1 In addition, approximately 25% of the US population reported 
experiencing chronic pain,1 with 18% of the population experiencing chronic low back 
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pain at any given time.2 Due to its widespread prevalence, 
pain constitutes an economic burden to society as well as 
the individual, as is clearly shown by the annual direct and 
indirect expenditures that were recently reported from the 
Institute of Medicine, which reported that pain costs the 
nation between US$560 and US$635 billion each year in 
both medical treatment and lost productivity.3 The financial 
impact of low back pain alone ranges from US$45 billion to 
US$54 billion per year.4
Patients’ pain experiences are often examined through 
self-report measures and behavioral observations. However, 
health care professionals also need to evaluate the degree 
to which patients want their pain and related domains 
to improve. A patient-centered outcomes questionnaire 
(PCOQ)5 was developed to measure the patient-centered 
expectations and criteria for success regarding treatment 
for chronic pain.
A study by Robinson and colleagues found that, based 
on an eleven-point numerical rating scale where 0 = “not at 
all important” and 10 = “most important,” patients deemed 
a mean reduction in their pain of 3.4 points (56%) a suc-
cessful treatment outcome.5 In addition, patients consid-
ered the following to be meaningful levels of success in 
treatment: a mean reduction of 3.4 points (57%) in their 
level of fatigue, 3.6 points (65%) in their level of overall 
distress, and 4.3 points (68%) in the level of interference of 
pain in their lives.5 Patients’ success criteria were shown to 
require a larger reduction in pain, distress, and fatigue than 
originally hypothesized, though patients did not expect to 
reach their own success criteria for the level of interference 
domain.5 Similarly, research has shown that, to consider 
treatment for pain successful, patients’ criteria for treat-
ment outcome are relatively high compared with health care 
professionals’ criteria.6,7
Standard clinical assessments typically consist of mea-
surements with a subjective cut-off score, or normative 
reference, also known as a minimal clinically important 
difference. The minimal clinically important difference has 
been used in pain studies in order to determine if patients 
change throughout treatment; it was found that a 30% change 
represented a clinically significant change in pain.8 However, 
reaching statistical significance (which may represent arti-
ficially inflated values based on a large sample size) does 
not unequivocally signify that patients have experienced a 
perceived successful degree of change.5,9 Several variables 
may influence findings, including sample size and degree of 
variability of improvement across patients, that is, greater 
improvement in some patients but deterioration in others.5,10 
The minimal clinically important difference does not 
  incorporate patients’ criteria of treatment outcomes, which 
can identify group differences in patients, based on which 
domains they wish to target in treatment. It is evident that 
patients have different criteria by which they measure the suc-
cess of their treatment. Therefore, health care professionals 
need to consult with patients to determine how their patients 
measure success in various domains, to determine how they 
can most effectively help their patient achieve this success.
A patient-centered approach focuses on patients’ needs, 
views, and expectations, and incorporates them into treatment 
decisions.11 The Patient-Generated Index12 is one measure 
that incorporates the patient’s perspective by examining 
the effect of a medical condition on quality of life; it also 
assesses the areas for improvement that are meaningful to 
the patient, and how realistic these expectations are in the 
areas of life patients want to change. In patient-centered 
models, patients have a more active and empowering role 
in structuring their treatment since they may have a dif-
ferent definition of success than their providers. Without 
patient involvement, success in treating pain is limited and 
patient suffering increases.13 With increased suffering, cost 
will likely rise as well.
This study aimed to first examine if patients who were 
treated at a multidisciplinary treatment center met their 
own success criteria in treatment at the 3-month follow-up 
  assessment. Based on previous literature5 it was hypothesized 
that patients would not fully meet their own success criteria 
in treatment, as it is believed that they typically require larger 
reductions across domains in treatment than they will actually 
attain. Secondly, in addition to investigating patients’ actual 
improvement against their success criteria, the researchers 
assessed the effect of brief cognitive behavioral therapy 
(CBT) and opioid treatments on expectations for treatment 
outcome from the patient perspective. It was anticipated that 
brief individualized CBT would have a greater influence on 
non-pain outcome expectations, whereas opioid treatment 
alone would primarily influence pain outcomes. Thirdly, we 
hypothesized that those who received brief CBT and opioid 
treatment would report greater actual success, as measured 
by the PCOQ, across the four domains, when compared with 
the opioid-only group, which would likely have a similar 
reduction in pain but lower levels of improvement in the 
other three domains (negative affect, fatigue, and interfer-
ence with daily functioning). The relative greater success 
was hypothesized to be due to the cognitive restructuring 
aspects of brief CBT and the focus on behavioral pain man-
agement techniques, as compared to the opioid only group. 
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Based on previous research, CBT has been successfully used 
as   treatment for chronic low back pain populations.14 Finally, 
the fourth aim was to examine the extent to which patients’ 
baseline expectations for treatment outcome predicted actual 
treatment outcome. Based on previous literature,15,16 it was 
hypothesized that there would be a positive correlation 
between expectation scores and outcomes.
Methods
Participants
Patients in the present study included 47 adults (20 female 
and 27 male) with chronic low back pain. Patients were 
recruited from the University of Florida Chronic Analgesic 
Management Program.
Design
This study had a two-group, pre-post design. The 
  post-treatment assessments occurred 3 months after the 
initial assessment.
Inclusion criteria dictated that patients be between the 
ages of 18 and 70 and have low back pain as their primary 
pain site. Additionally, pain must have been present for a 
minimum of 3 months. Exclusionary criteria included a his-
tory of drug abuse or dependency within the past 5 years, 
presence of any medical condition where opioids were con-
traindicated, or psychosis.
Procedure
The University of Florida Institutional Review Board 
approved the procedures and protocols of the study. Informed 
consent was obtained from all participants. Patients were 
recruited and randomized to one of two conditions. The first 
condition consisted of brief individualized CBT and opioid 
medication, while the second condition consisted of opioid 
medication only. Both conditions were monitored weekly 
for 10 weeks for side effects.
All patients were on opioids, though the opioid medica-
tion varied according to individual prescriptions. Treatment 
condition assignment was conducted independent of medica-
tion usage. In terms of both short- and long-acting medication 
usage, no significant differences were found between the 
CBT group and the opioid-only group at baseline (X2 [n = 47, 
degrees of freedom (df) = 1] = 1.52, P . 0.05), nor at the 
3-month follow-up (X2 [n = 47, df = 1] = 0.195, P . 0.05). 
Patients randomized to the CBT and opioids group partici-
pated in brief CBT provided in an individualized format; thus, 
the length of therapy varied across patients. CBT sessions 
were each 1 hour in length and performed by therapists with 
specific training in the use of CBT with chronic pain. Each 
session consisted of a combination of skill and homework 
review, as well as new skill acquisition. Individualized CBT 
was utilized in order to tailor treatment to the patient and 
target domains that were clinically relevant to the individual. 
Skills learned in this brief intervention were taught according 
to individual needs; these included new ways to conceptualize 
pain (gate control theory); psychoeducation; pleasant activity 
scheduling; and examining the relationship between thoughts, 
feelings, and behaviors that may have been maintaining or 
exacerbating the patient’s pain. Patients were also taught 
adaptive coping skills, such as activity pacing, and a variety 
of relaxation techniques.
Measures
Demographic questionnaire
Patients completed a demographic questionnaire inquiring 
about their age, sex, race/ethnicity, and number of years of 
formal education attained.
PCOQ
The PCOQ consists of four domains – (1) pain, (2) fatigue, 
(3) emotional distress, and (4) interference with daily activi-
ties – rated on a 0–100 scale. Each of the four domains is 
measured on five levels: (1) usual levels, (2) desired levels, 
(3) treatment outcomes for success, (4) expectations of treat-
ment, and (5) importance of improvements. Reliability for 
the PCOQ ranges from 0.84 to 0.90 (P , 0.001) for usual 
levels of pain, fatigue, distress, and interference. Recently 
published data regarding PCOQ psychometric properties 
demonstrated good concurrent validity.6
Statistical methods
All statistical analyses were conducted using SPSS® PASW 
18 (IBM Corporation, Armonk, NY). For the first aim, 
addressing whether patients met their own success criteria, 
success criteria scores were calculated by finding the dif-
ference between patients’ usual levels across domains and 
corresponding success criteria. In addition, actual change 
scores from pre- to post-treatment were calculated to see if 
patients matched their own success criteria, and then descrip-
tive statistics were run. For the second and third aims of the 
study, repeated measures analyses of variance (ANOVA), 
under the general linear model, were performed to determine 
if there were significant differences found in each of the four 
domains from pre- to post-treatment, as well as between the 
two treatment groups. For the final aim, residualized change 
scores were used to determine the relationship between 
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baseline expectations for change and actual outcome across 
the four domains.
Results
The final sample consisted of 47 adult patients; descrip-
tive statistics are presented in Table 1. To address the first 
aim of the study, we examined success criteria as defined 
by patients, and then determined if patients met their own 
criteria. Patients indicated on a scale of 0–100 that they 
considered treatment success with regards to their level 
of pain to be a mean reduction of 50.91 points in pain; 
however, on average, patients only reached a reduction of 
11.93 points. This finding indicates that patients did not 
meet their own criterion. In addition, patients reported that 
their success criterion for overall distress would be a mean 
reduction of 34.62 points, though they instead experienced 
a mean 0.43 point increase in their level of emotional 
distress. In addition, patients reported that they sought a 
mean reduction of 40.62 points in the level of fatigue they 
were experiencing, though they had an actual decrease of 
3.99 points in the fatigue domain. Lastly, patients indicated 
that success in their overall level of interference would 
be a mean reduction of 49.34 points; they experienced an 
actual mean reduction of 10.04 points. Results of dependent 
t-tests confirmed that these differences were statistically 
reliable (P , 0.001), indicating that patients did not meet 
their success criteria for any domain. These results are 
presented in Table 2.
To address the second aim of the study, which examined 
low back pain patients’ change in expectation from pre- to 
post-treatment, a series of 2 (group) × 2 (time) repeated 
measures ANOVA analyses were performed to assess differ-
ences for each of the four patient-centered outcome domains. 
Results indicated that there were no significant changes in the 
four domains across time, irrespective of group assignment. 
There were no significant group-by-time interaction effects 
across the patient-centered outcome domains. For detailed 
results see Table 3.
For the third aim of the study, the change in usual level 
of each domain over time (from pre- to post-treatment) 
across the two treatment groups was examined using 
a repeated measures 2 (group) × 2 (time) ANOVA. 
For the pain domain, results indicated that there was a 
significant effect of time, indicating that both groups 
reported a decrease in pain from pre- to post-treatment 
(F[1, 45] = 11.98, P , 0.001). For the interference 
domain, there was a significant main effect of time (F[1, 
45] = 5.46, P , 0.05). These results indicate that both 
groups reported a significant decrease in their interfer-
ence of daily living activities. There were no significant 
effects of time for emotional distress or fatigue. There were 
no significant group-by-time interactions for any of the 
analyses. For a complete report of results across PCOQ 
domains, see Table 4.
To determine a relationship between expectations and 
actual change (aim 4), residualized change scores were 
first calculated by regressing pretreatment scores on post-
treatment scores for participants’ usual levels across the 
four domains. Subsequently, correlations between patients’ 
pretreatment expectations of treatment-induced change and 
their residualized change scores on usual levels of pain, 
fatigue, emotional distress, and level of interference were 
conducted. Results indicated that pretreatment expectations 
for change were not significantly correlated with the cor-
responding change of usual level of pain, fatigue, distress, 
Table 1 Participant demographics (n = 47)
Mean SD %
Age 48.23 9.89
Formal education (years) 11.17 4.07
Duration of pain (months) 138.41 107.55
Sex
  Female 20 42.6
  Male 27 57.4
Race
  Caucasian 38 80.9
  African-American 7 14.9
  Hispanic/Latino 2 4.2
Baseline “usual” levels
  Pain 77.19 18.19
  Fatigue 61.53 23.94
  Emotional distress 48.23 31.72
  Level of Interference 67.45 28.78
Post-treatment “usual” levels
  Pain 65.26 22.88
  Fatigue 57.64 25.87
  Emotional distress 48.28 28.36
  Level of Interference 57.4 30.18
Abbreviation: SD, standard deviation.
Table 2 Comparison of patients’ treatment success criteria with 
actual improvements achieved
PCOQ  
domain
Patients’  
success criteria 
(mean)
Reduction  
attained 
(mean)
t Cohen’s   
d
Pain 50.91 11.93 10.89* 3.21
Emotional  
distress
34.62 -0.43 8.26* 2.44
Fatigue 40.62 3.89 10.25* 3.02
Interference 49.34 10.04 8.91* 2.63
Notes: Scale = 0–100; *P , 0.001. 
Abbreviation: PCOQ, patient-centered outcomes questionnaire.
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or level of interference. See Table 5 for a report of correla-
tions across domains.
Discussion
The first aim of the present study examined whether patients 
met their own treatment success criteria by the end of 
treatment. Results indicated that, overall, patients did not 
meet their own success criteria, a finding consistent with 
Table 3 Patients’ change in expectation from pre- to post-treatment
PCOQ domain CBT + opioids Opioids F η2 P
Pretreatment
Mean (SD)
Post-treatment
Mean (SD)
Pretreatment
Mean (SD)
Post-treatment
Mean (SD)
Pain 28.46 (18.59) 29.04 (20.39) 28.57 (25.50) 37.38 (28.00)  
  Time 1.38 0.03 .0.05
  Group 0.60 0.01 .0.05
  Time × group 1.06 0.02 .0.05
Fatigue 23.85 (18.18) 20.19 (17.41) 23.10 (25.71) 26.19 (24.23)
  Time 0.01 0.00 .0.05
  Group 0.26 0.01 .0.05
  Time × group 0.94 0.02 .0.05
Emotional distress 20.58 (19.30) 18.46 (17.93) 17.14 (27.18) 22.86 (25.00)
  Time 0.26 0.01 .0.05
  Group 0.01 0.00 .0.05
  Time × group 1.23 0.03 .0.05
Interference 21.73 (21.58) 18.85 (18.46) 28.10 (31.36) 25.00 (27.70)
  Time 0.48 0.01 .0.05
  Group 1.14 0.03 .0.05
  Time × group         0.00 0.00 .0.05
Abbreviations: CBT, cognitive behavioral therapy; PCOQ, patient-centered outcomes questionnaire; SD, standard deviation.
Table 4 Patients’ change in usual levels from pre- to post-treatment
PCOQ domain CBT + opioids Opioids F η2 P
Pretreatment
Mean (SD)
Post-treatment
Mean (SD)
Pretreatment
Mean (SD)
Post-treatment
Mean (SD)
Pain 74.73 (18.47) 68.08 (19.19) 80.24 (17.81) 61.76 (26.84)  
  Time 11.98** 0.21 ,0.001
  Group 0.01 0.00 .0.05
  Time × group 2.65 0.06 .0.05
Fatigue 60.96 (22.32) 59.04 (24.78) 62.24 (26.35) 55.90 (27.68)
  Time 0.98 0.02 .0.05
  Group 0.02 0.00 .0.05
  Time × group 0.28 0.01 .0.05
Emotional distress 53.58 (31.42) 53.27 (25.96) 41.62 (31.58) 42.10 (30.57)
  Time 0.00 0.00 .0.05
  Group 2.31 0.05 .0.05
  Time × group 0.01 0.00 .0.05
Interference 65.00 (29.16) 57.31 (28.78) 70.48 (28.72) 57.52 (32.54)
  Time 5.46* 0.11 , 0.05
  Group 0.14 0.00 .0.05
  Time × group         0.35 0.01 .0.05
Notes: *P , 0.05; **P , 0.001.
Abbreviations: CBT, cognitive behavioral therapy; PCOQ, patient-centered outcomes questionnaire; SD, standard deviation.
  previous literature.5 Consistent with our hypothesis, the 
amount of change necessary for patients to consider their 
treatment successful was of much greater magnitude than 
the change actually achieved with treatment. Patients’ 
treatment-related improvements did not meet their success 
criteria for any of the four domains examined. In addition, 
this shows that opioids are not effective in successfully treat-
ing chronic low back pain. The failure of treatment to meet 
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patients’   success criteria may explain why patients often try 
  numerous therapies and medication approaches; perhaps they 
are   dissatisfied with current treatment approaches that do 
not beget improvements corresponding to their own success 
criteria for treatment.
The present study further explored patient-centered 
assessment and outcomes across four functional domains. 
The PCOQ was originally designed to measure various 
domains of functioning in a chronic pain population. This 
study administered the measure to a chronic low back pain 
sample in order to examine specific expectations this sample 
may have had, and to determine how expectations may have 
changed over time. This study sought to examine if chronic 
low back pain participants’ expectations for change within 
the four domains differed from pre- to post-treatment based 
on group assignment.
This hypothesis was based on the premise that the con-
structs of CBT would effect changes in expectations through 
cognitive restructuring; therefore, it was hypothesized that 
the opioid-only group would not experience systematic 
changes in expectations with regard to level of interference, 
fatigue, or distress as compared to the brief CBT and opioids 
group. Contrary to our hypothesis, as well as to previous 
research on the role of expectations17 there were no signifi-
cant differences between groups or across time for all other 
domains. The lack of findings on a role of expectations could 
be attributed to a power issue, due to a small sample size. As 
seen in Table 3, effect sizes are quite small. Since patients 
did not meet their own criteria for success, it is possible that 
expectations did not significantly change because patients 
still had expectation for a reduction in pain and related 
domains even after treatment had ended; they might have 
hoped to still experience change. Based on what is implied 
in the instructions, the PCOQ may not assess patients’ 
perceptions of the magnitude of improvement achieved at 
treatment termination but may reflect how much they will 
continue to improve following treatment.
This study also aimed to determine how change in usual 
levels of pain, fatigue, disability, and level of   interference 
varied according to the type of treatment delivered to 
  participants. No differences in usual levels of pain, fatigue, 
disability, or level of interference were found between the 
two treatment groups. A main effect of time was found in the 
pain domain, indicating that both treatment groups improved 
significantly from pre- to post-treatment, though the expected 
benefit from brief CBT beyond that of the opioid-only treat-
ment was not supported.
Lastly, this study aimed to determine how expectations 
influence actual change. However, our results did not confirm 
our original hypothesis that there would be a correlation 
between baseline expectations and outcome of usual levels 
of pain, fatigue, distress, and level of interference. Given the 
small changes in all domains relative to patient criteria for 
success, this may have minimized the expectation and actual 
change relationship. This sample was particularly chronic 
and previous experience with treatments may have limited 
their expectations for success.
Few patient-centered approaches for the evaluation of 
expectations and treatment outcome in a chronic pain popula-
tion have been examined. The PCOQ offers a novel approach 
to examining chronic low back pain patients’ changes in 
expectation and provides important information to contribute 
to the pain literature.
Although the study had significant strengths, it is crucial 
to address some potential limitations. One potential limita-
tion of the study may be the delivery and duration of the 
CBT. The current study employed standard clinical care but 
did not follow a manualized treatment protocol, which may 
have reduced the effectiveness of the CBT. Future studies 
may consider providing manualized CBT of  longer duration. 
Future research should investigate the usefulness of CBT, 
as compared with opioids, by adding another treatment 
group where patients receive CBT only so that results can 
be more conclusive. Reliability and validity of the PCOQ 
can be further examined in future studies to better ensure 
that chronic low back pain patients’ domains of function-
ing are being measured in a meaningful and accurate way. 
Finally, this study was limited in that it had a sample size of 
only 47 participants.
Conclusion
Results replicated previous findings indicating that patient 
criteria for success are not met by opioid and CBT-enhanced 
opioid treatment. As far as the authors are aware, the pres-
ent study is the most recent to show that current treatments 
fall considerably short of patients’ criteria for success. 
Future directions for development of chronic pain treatment 
Table 5 Pretreatment expectation and pre- to post-treatment 
change in usual level ratings
r P
Change in pain 0.08 .0.05
Change in emotional distress 0.03 .0.05
Change in fatigue 0.02 .0.05
Change in level of interference -0.02 .0.05
Note: Degrees of freedom = 45.
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necessitate the establishment of more effective analgesic 
  strategies, or more targeted interventions aimed at more 
realistic expectations for current treatments. Patients’ expec-
tations at pretreatment did not predict treatment outcome, 
probably because the magnitude of change was quite low, 
and the group may have had low expectations based on the 
chronicity of their pain. It is important that the expectations 
of individuals with chronic low back pain, and how these 
relate to their treatment outcome, are investigated in the 
future. The information collected will help inform clinical 
treatment (eg, expectations may need to be targeted as part of 
treatment or addressed more specifically in treatment) with 
the goal of attaining future improvements that can facilitate 
a greater degree of pain relief and pain-related sequelae for 
chronic low back pain patients.
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Appendix
Patient-centered outcomes  
questionnaire
Many people experience pain, fatigue (ie, feeling 
tired),   emotional distress (eg, worries, feeling sad), and 
  interference with daily activities (eg, not being able to 
work or do household chores) as a result of their medi-
cal condition. We would like to understand how you have 
been impacted in each of these areas. We would also like 
to learn more about what you want your treatment to do 
for you.
First, we would like to know your usual levels of pain, 
fatigue, emotional distress, and interference.
On a scale of 0 (none) to 10 (worst imaginable), please 
indicate your usual level (during the past week) of …
  •  pain _____
  •  fatigue (or tiredness) _____
  •  emotional distress _____
  •  interference with daily activities ______
Now, we would like to learn about your desired levels of 
pain, fatigue, emotional distress, and interference. In other 
words, we would like to understand what your ideal treatment 
outcome would be.
On a scale of 0 (none) to 10 (worst imaginable), please 
indicate your desired level of …
  •  pain _____
  •  fatigue (or tiredness) _____
  •  emotional distress _____
  •  interference with daily activities _____
Patients understandably want their treatment to result 
in desired or ideal outcomes like you indicated above. 
  Unfortunately, available treatments do not always   produce 
desired outcomes. Therefore, it is important for us to understand 
what treatment outcomes you would consider successful.
On a scale of 0 (none) to 10 (worst imaginable), please 
indicate the level each of these areas would have to be at for 
you to consider treatment successful.
  •  pain _____
  •  fatigue (or tiredness) _____
  •  emotional distress _____
  •  interference with daily activities _____
Now, we would like to know what you expect your treat-
ment to do for you.
On a scale of 0 (none) to 10 (worst imaginable), please 
indicate the levels you expect following treatment.
  •  pain _____
  •  fatigue (or tiredness) _____
  •  emotional distress _____
  •  interference with daily activities _____
Finally, we would like to understand how important it is 
for you to see improvement in your pain, fatigue, emotional 
distress, and interference following treatment.
On a scale of 0 (not at all important) to 10 (most impor-
tant), please indicate how important it is for you to see 
improvement in your …
  •  pain _____
  •  fatigue (or tiredness) _____
  •  emotional distress _____
  •  interference with daily activities _____
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